Skip to main content
. 2020 Mar 24;21:150–154. doi: 10.1016/j.jor.2020.03.015

Table 2.

Infection type, treatment strategy, and outcomes.

Patient Orthopaedic infection(s) Date of positive GAS culture Surgical management Antibiotic Regimen Total Antibiotic Duration ID consult Initial and final ESR mm/hr) Initial and final CRP (mg/dL) Cure at 90 days Comments
1 Right leg necrotizing fasciitis, osteomyelitis; prior tibial ORIF 7/3/2017 I&D and fasciotomy 2 weeks of IV vancomycin/piperacillin-tazobactam/clindamycin or IV penicillin, then 4 weeks of PO amoxicillin/clavulanate 6 weeks Y 110, 39 42.4, 3.7 Yes IVIG X 3 days
2 Left hand flexor tenosynovitis 9/18/2018 I&D IV Ceftriaxone and metronidazole for 4 days, then PO amoxicillin/clavulanate for 10 days 2 weeks Y 55, not done 6.3, not done Yes
3 Right hand flexor tenosynovitis 10/20/2018 I&D IV Ampicillin/sulbactam for 3 days, then PO amoxicillin/clavulanate for 2 weeks 17 days Y 101, 47 4.2, 0.8 Yes
4 Left foot necrotizing fasciitis and osteomyelitis 10/24/2018 I&D, below knee amputation IV Vancomycin and piperacillin/tazobactam for 5 days, then IV ceftriaxone andclindamycin for 1 week, then PO linezolid for 17 days 4 weeks Y >140, >140 33.4, 9.7 No
5 Left foot osteomyelitis 10/18/2018 Foot amputation PO Linezolid for 4 weeks 4 weeks Y 46, not done 2.4, not done No
6 Right foot osteomyelitis 11/30/2018 None IV Vancomycin and piperacillin/tazobactam for 3 days 3 days N 72, not done 1.8, not done No Patient left against medical advice; had co-infection with P. multocida
7 Right foot necrotizing fasciitis and osteomyelitis 11/24/2018 Foot amputation IV Vancomycin and piperacillin/tazobactam for 4 days, then IV ceftriaxone and clindamycin for 3 days, then IV ampicillin/sulbactam for 2 weeks 3 weeks Y 85, not done 30.8, not done Yes Co-infection with MSSA
8 Left hip and femur septic arthritis and osteomyelitis 12/30/2018 I&D IV Vancomycin and ceftriaxone for 1 week, then PO cephalexin for 6 weeks 7 weeks Y 40, not done 4.5, <0.5 Yes
9 Right ankle prosthetic joint infection 12/12/2018 I&D and prosthesis removal with antibiotic bead placement, followed by revision IV Ceftriaxone and clindamycin for 1 week, then IV ceftriaxone alone for 5 weeks 6 weeks Y 114, 41 17.3, 0.7 Yes
10 Right foot osteomyelitis 12/3/2018 Foot amputation IV Vancomycin and ciprofloxacin for 5 days, then IV cefazolin for 1 week 12 days Y 35, not done 3.5, not done No Co-infection with MSSA
11 Right leg necrotizing fasciitis and osteomyelitis 12/2/2018 Below knee amputation IV Vancomycin, clindamycin and meropenem for 11 days 11 days prior to in-hospital death Y 27, not done 31.2, not done No Co-infection with P.stuartii, deceased within 90 days from fungemia
12 Right knee prosthetic joint infection 2/19/2019 I&D, one-stage prosthesis revision IV Ceftriaxone and clindamycin for 1 week, then IV ceftriaxone alone for 5 weeks, then PO cephalexin chronic suppression 6 weeks, then chronic suppression Y 53, 28 3.4, 1.5 Yes Suppressive cephalexin for ≥1 year due to immuno-suppressive therapy for RA
13 Right ankle achilles tenosynovitis overlying prior ORIF site 4/11/2019 I&D, antibiotic beads placement, followed by skin graft Vancomycin and piperacillin/tazobactam for 3 days, then cefazolin for 3 days then linezolid for 2 weeks 3 weeks Y 30, not done 0.9, not done Yes Co-infection with MSSA

IV: intravenous, PO: oral, ESR: erythrocyte sedimentation rate, I&D: incision and drainage, IVIG: intravenous immunoglobulin, MSSA: methicillin-susceptible S. aureus, RA: rheumatoid arthritis.